The Harvard Management Company increased its direct holdings of Alphabet and Meta and continued its major sell off of biopharma holdings — which now make up less than 1 percent of the portfolio — during the last three months of 2023.
Hung oversees an endowment that seeks to capitalize on the team’s proximity to the University of Wisconsin-Madison, a public land grant research university.